The relationship of menopausal status and serum ferritin to cardiovascular risk

Women's Health Issues

Volumn 7, Issue 1, 1997, Pages 55-63

  Penckofer, Sue M ^a   Holm, Karyn ^a   Schwertz, Dorie ^b   Chandler, Peggy ^b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ESTRADIOL; FERRITIN; FOLLITROPIN;

ADULT; AGING; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; ESTRADIOL BLOOD LEVEL; FEMALE; FERRITIN BLOOD LEVEL; FOLLITROPIN BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; MENOPAUSE; NORMAL HUMAN; POSTMENOPAUSE; PREMENOPAUSE; SMOKING; SYSTOLIC BLOOD PRESSURE;

EID: 0031025715     PISSN: 10493867     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1049-3867(96)00049-7     Document Type: Article

References (29)

1. 1. American Heart Association. Heart and Stroke Facts: 1995 Statistical Supplement. Dallas (TX): American Heart Association, 1995.
2. 2. Penckofer S, Holm K. Poll report: examining women's risk for heart disease. Nursing 1994;94(January):42-5.
3. 3. Rich-Edwards JW, Manson JE, Hennekens CH, Buring JE. The primary prevention of coronary heart disease in women. New Engl J Med 1995;332:1758-66.
4. 4. Stampfer M, Colditz G, Willett W, Manson J, Rosner B, Speizer F, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. New Engl J Med 1991;325:756-62.
5. 5. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995;273: 199-208.
6. 6. Sullivan J. The iron paradigm of ischemic heart disease. Am Heart J 1989;117:1177-88.
7. 7. Salonen J, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86:803-11.
8. 8. Morrison HI, Semenciw RM, Mao Y, Wigle DT. Serum iron and risk of fatal acute myocardial infarction. Epidemiology 1994;5:243-6.
9. 9. Halliwell B. Free radicals, antioxidants and human disease: curiosity, cause or consequence. Lancet 1994;344:721-4.
10. 10. Skikne B, Cook J. Serum ferritin in the evaluation of iron status. Lab Manage 1981;May:31-5.
11. 11. Cross C, Halliwell B, Borish E, Pryor W, Ames B, Saul R, et al. Oxygen radicals and human disease. Ann Int Med 1987;107:526-45.
12. 12. Steinberg D, Parthasarathy S, Carew T, Khoo J, Witztum J. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. New Engl J Med 1989;320:915-24.
13. 13. Holm K, Wilbur J, Dan S, Kukreja S. Physical activity pattern and bone mineral density. National Center for Nursing Research, 1987 (Grant: 1R01 NUO 1453-04).
14. 14. Cook J, Finch C, Smith N. Evaluation of the iron status of a population. Blood 1976;48:449-55.
15. 15. Guetta V, Panza J, Waclawiw M, Cannon R. Effect of combined 17β-estradiol and vitamin E on low-density lipoprotein oxidation in postmenopausal women. Am J Cardiol 1995;75:1274-6.
16. 16. Sack M, Rader D, Cannon R. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 1994;343:269-70.
17. 17. Penckofer S, Holm K, Bremner WF, Euler D, Schwertz D, Sexton R. Estrogen replacement therapy and oxidative stress in postmenopausal women. Grant-in-Aid, American Heart Association of Metropolitan Chicago, 1995.
18. 18. Speroff, L, Glass RH, Kase NG. Clinical gynecologic endocrinology and infertility, 5th ed. Baltimore (MD): Williams & Wilkins, 1994.
19. 19. Wren BG. The effect of oestrogen on the female cardiovascular system. Med J Aust 1992;57:204-8.
20. 20. Holm K, Penckofer S. Coronary heart disease: requisite knowledge for developing prevention strategies for the aging adult. Prog Cardiovasc Nurs 1990;5:118-25.
21. 21. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Monson RR, et al. A prospective study of obesity and risk of coronary heart disease in women. New Engl J Med 1990;322:882-9.
22. 22. Holm K, Penckofer S, Keresztes P, Biordi D, Chandler P. Women's issues in women's health nursing: coronary artery disease in women: assessment, diagnosis, intervention and strategies for life style change. AWHONN's Clin Issues Perinat Womens Health Nurs 1993;4:272-85.
23. 23. Lauffer RB. Exercise as prevention: do the health benefits derive in part from lower iron levels? Med Hypotheses 1991;35:103-7.
24. 24. Fogelholm M, Jaakkola L, Lampisjarvi T. Effects of iron supplementation in female athletes with low serum ferritin concentration. Int J Sports Med 1992;13:158-62.
25. 25. Rosenberg L, Palmer JR, Shapiro S. Decline in the risk of myocardial infarction among women who stop smoking. New Engl J Med 1990;322:213-7.
26. 26. Milman N, Kirchhoff M, Jorgensen T. Iron status markers, serum ferritin and hemoglobin in 1359 Danish women in relation to menstruation, hormonal contraception, parity, and postmenopausal hormone treatment. Ann Hematol 1992;65:96-102.
27. 27. Baer D, Tekawa I, Hurley L. Iron stores are not associated with acute myocardial infarction. Circulation 1994;89:2915-8.
28. 28. Magnusson M, Sigfusson N, Sigvaldason H, Johannesson G, Magnusson S, Thorgeirsson G. Low iron-binding capacity as a risk factor for myocardial infarction. Circulation 1994;89:102-8.
29. 29. Gordon T, Kannel W, Hjortland M, McNamara P. Menopause and coronary heart disease: the Framingham Study. Ann Intern Med 1978;89:157-61.